Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-022089)

Filing Details

Accession Number:: 0001181431-13-022089
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-12 16:15:45
Reporting Period:: 2013-04-10

Filing Date:: 2013-04-12
Accepted Time:: 2013-04-12 16:15:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1349929	Cancer Genetics Inc	CGIX	Services-Medical Laboratories (8071)	043462475

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1550335	S.k. Raju Chaganti	201 Route 17 North 2Nd Floor Rutherford NJ 07070		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Convertible Note	Acquisiton	2013-04-10	13,430	$0.00	438,727	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Convertible Note	Disposition	2013-04-10	0	$0.00	13,430	$10.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

The outstanding principal balance under the convertible note plus all accrued and unpaid interest thereon converted into shares of common stock of Cancer Genetics, Inc. (the "Company") upon consummation of the Company's initial public offering at a conversion price per share equal to the initial public offering price per share. The convertible note had no expiration date.